Personalised medicine is estimated to grow to two billion euros by 2018. Redistributed Manufacturing (RDM) has the potential to support this growth. This involves a shift towards more localised production, enabling faster response, lower cost or better preservation of sensitive goods. RDM can provide tailored, right-first-time treatments to all patients, allowing for the best therapy for an individual patient to be rapidly determined. However, as the Engineering and Physical Sciences Research Council (EPSRC) points out, there are a range of technical and managerial challenges as well as business, regulatory and resource implications which must be understood and solved.
This workshop will be hosted by Redistributed Manufacturing Healthcare Research Network (RiHN). The RiHN aims to deliver a single vision of the research needed to position the UK at the forefront of healthcare manufacturing. Network partners include cross disciplinary researchers from the Universities of Cambridge, Brunel, Nottingham, Newcastle, Loughborough and the West of England. The network is sponsored by the EPSRC and is supported by Innovate UK.
This free to attend event gives participants an opportunity to network with healthcare professionals, scope out R&D issues from a multi-disciplinary perspective, establish early stage collaborations and formulate potential areas of investigation that can be tested and scaled up into larger R&D programmes.
Key outputs from the day will help shape a future call in June 2015, which will invite bids to compete for 5-6 feasibility studies, worth £65k each. If you have an interest in pharmaceuticals and advanced therapeutics, we strongly recommend that you attend. This is the second of two workshops; the first was oriented towards medical devices, diagnostics and dentistry.
Date: 28 April 2015
Venue: Vaughan Parry Williams Pavillion, Highfields Sports Ground, University of Nottingham, University Park Campus